Stuart J. Heminway

Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention

Paul D. Crane, Robert J Laliberte, Stuart J. Heminway et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1993 · 195 citations

Medicine, Cardiology, Nuclear Medicine +13

Labeling a Hydrazino Nicotinamide-Modified Cyclic IIb/IIIa Receptor Antagonist with ^99mTc Using Aminocarboxylates as Coligands

Shuang Liu, David S. Edwards, Richard Looby et al. · Bioconjugate Chemistry · 1996 · 118 citations

Medicine, Medicinal Chemistry, Pharmacology +17

New and Versatile Ternary Ligand System for Technetium Radiopharmaceuticals:  Water Soluble Phosphines and Tricine as Coligands in Labeling a Hydrazinonicotinamide-Modified Cyclic Glycoprotein IIb/IIIa Receptor Antagonist with ^99mTc

David S. Edwards, Shuang Liu, John Barrett et al. · Bioconjugate Chemistry · 1997 · 109 citations

Medicine, Pharmaceutics, Pharmacology +17

Biological Evaluation of Thrombus Imaging Agents Utilizing Water Soluble Phosphines and Tricine as Coligands When Used To Label a Hydrazinonicotinamide-Modified Cyclic Glycoprotein IIb/IIIa Receptor Antagonist with ^99mTc

John Barrett, A. C. Crocker, David J. Damphousse et al. · Bioconjugate Chemistry · 1997 · 57 citations

Medicine, Pharmaceutics, Pharmacology +15

Biological Evaluation of ^99mTc-Labeled Cyclic Glycoprotein IIb/IIIa Receptor Antagonists in the Canine Arteriovenous Shunt and Deep Vein Thrombosis Models:  Effects of Chelators on Biological Properties of [^99mTc]Chelator−Peptide Conjugates

John Barrett, David J. Damphousse, Stuart J. Heminway et al. · Bioconjugate Chemistry · 1996 · 49 citations

Medicine, Medicinal Chemistry, Pharmacology +15